Palatin Technologies Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$9.36

-0.64 (-6.40%)

As of Aug 15, 2:29 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +41.8% upside

Low Target $11.80

Average Target $13.27

High Target $20.48

Current Price $9.36

Current
$9.36

Target
$13.27

$11.80 $13.27 avg $20.48

Scenario Analysis

Bear Case

$11.80

26.1%

Low target

Base Case

$13.27

+41.8%

Avg target

Bull Case

$20.48

+118.8%

High target

Risk/Reward

4.6x

Highly favorable

Price in Context

52-Week High

$31.00

-69.8% from high

52-Week Low

$5.00

+87.2% from low

Target vs 52W High

$13.27

-57.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%